PRESS RELEASE published on 07/17/2026 at 00:00, 9 days 5 hours ago LUMIBIRD ENTRE EN NÉGOCIATION EXCLUSIVE EN VUE DE LA CESSION DE SA DIVISION MÉDICALE À IPG PHOTONICS CORPORATION Lumibird entre en négociation exclusive pour céder sa division médicale à IPG Photonics Corporation. Une décision clé pour le développement de Lumibird et sa stratégie future Cession Négociation Exclusive LUMIBIRD Division Médicale IPG Photonics Corporation
PRESS RELEASE published on 07/16/2026 at 23:20, 9 days 5 hours ago Anatomie Launches $4M Series B to Redefine Luxury Travel Wear Miami, FL, USA, July 16th, 2026, FinanceWire
PRESS RELEASE published on 07/16/2026 at 23:10, 9 days 5 hours ago EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration Marinomed Biotech AG to apply for court restructuring proceedings without self-administration due to failed negotiations and insolvency risk. Aim to secure financial stability Marinomed Biotech AG Financial Stability Insolvency Risk Restructuring Proceedings Court-approved Restructuring Plan
PRESS RELEASE published on 07/16/2026 at 23:09, 9 days 5 hours ago Ataman Studio Is Making Custom Home Design in California Less Painful LOS ANGELES, CA, USA, July 16th, 2026, FinanceWire
PRESS RELEASE published on 07/16/2026 at 22:36, 9 days 6 hours ago Marquis Who’s Who Honors Holt Harmon as an Expert in Artist Management Uniondale, NY, USA, July 16th, 2026, FinanceWire
PRESS RELEASE published on 07/16/2026 at 22:10, 9 days 6 hours ago DBV Technologies publie son Rapport Financier Semestriel 2026 ? Modalités de mise à disposition ou de consultation DBV Technologies publie son Rapport Financier Semestriel 2026 et le rend disponible pour consultation en ligne Investisseurs DBV Technologies Allergies Alimentaires Viaskin Rapport Financier Semestriel 2026
PRESS RELEASE published on 07/16/2026 at 22:10, 9 days 6 hours ago DBV Technologies Announces the Filing of its 2026 Half-Year Report ? Conditions for Accessing or Consulting the Report DBV Technologies files 2026 Half-Year Report with French market authority AMF. Company develops treatments for food allergies with VIASKIN patch technology Half-year Report DBV Technologies Food Allergies French Market Authority VIASKIN Patch Technology
PRESS RELEASE published on 07/16/2026 at 22:01, 9 days 7 hours ago DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2026 et fait le point sur ses activités DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2026, présente ses avancées dans le dossier de demande de licence biologique pour VIASKIN® Peanut et annonce une conférence téléphonique Résultats Financiers Conférence Téléphonique DBV Technologies Viaskin Peanut BLA
PRESS RELEASE published on 07/16/2026 at 22:01, 9 days 7 hours ago DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update DBV Technologies reports financial results and operational highlights for the second quarter and half-year of 2026, including regulatory progress with the FDA and cash position update Financial Results Cash Position Operational Highlights DBV Technologies FDA Engagement
Published on 07/25/2026 at 00:35, 1 day 4 hours ago Pathfinder Ventures Inc. Provides Corporate Update
Published on 07/24/2026 at 23:00, 1 day 6 hours ago NV Gold Announces Closing of Non-Brokered Private Placement
Published on 07/24/2026 at 22:15, 1 day 6 hours ago Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Published on 07/24/2026 at 22:05, 1 day 6 hours ago Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Published on 07/24/2026 at 20:00, 1 day 9 hours ago Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update
Published on 07/24/2026 at 18:44, 1 day 10 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/24/2026 at 18:15, 1 day 10 hours ago EUROPLASMA: Tirage des deux premières tranches du financement obligataire en vue de l’émission de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2 M€
Published on 07/24/2026 at 17:50, 1 day 11 hours ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/24/2026 at 18:50, 1 day 10 hours ago Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 18:50, 1 day 10 hours ago Déclaration hebdomadaire d'opérations effectuées du 20 au 24 juillet 2026
Published on 07/24/2026 at 18:23, 1 day 10 hours ago Communiqué relatif au dépôt d'offre publique de retrait visant les actions Bourrelier Group